Skip to main content
. 2015 Sep 30;32(9):823–837. doi: 10.1007/s12325-015-0246-9

Table 4.

Adverse events

Adverse events
Mild Moderate Total
Patients included in safety analysis 166 166 166
Number of events (number of cases) 38 (22) 4 (4) 42 (26)
Type n % n % n %
Eye disorders 34 3 37
 Eye lid sulcus deepened 8 4.8 8 4.8
 Growth of eyelashes 5 3 5 3
 Blepharal pigmentation 3 1.8 1 0.6 4 2.4
 Superficial punctate keratopathy 4 2.4 4 2.4
 Dry eyes 3 1.8 3 1.8
 Foreign body sensation in eyes 2 1.2 2 1.2
 Eyelid ptosis 1 0.6 1 0.6
 Eye irritation 1 0.6 1 0.6 2 1.2
 Eye pruritus 1 0.6 1 0.6 2 1.2
 Iritis 1 0.6 1 0.6
 Keratitis 1 0.6 1 0.6
 Vision blurred 1 0.6 1 0.6
 Visual acuity reduced 1 0.6 1 0.6
 Conjunctival hyperemia 1 0.6 1 0.6
 Corneal epitheliopathy 1 0.6 1 0.6
Other 4 1 5
 Blood pressure increased 1 0.6 1 0.6
 Headache 1 0.6 1 0.6
 Herpes zoster 1 0.6 1 0.6
 Itchy skin 1 0.6 1 0.6
 Rash 1 0.6 1 0.6